#开年拼经济#【晶泰科技创始人：中国发展AI药品研发优势明显】 晶泰科技联合创始人、董事长温书豪在接受CGTN主持人@蒉莺春Kate 采访时表示，中国发展AI药品研发，在硬件、人才和供应链方面均有优势。他还表示，在中国发展全球业务、让欧美企业为技术买单，是条可以成功的路径。China has clear advantages in AI-driven drug development in terms of hardware, talent, and supply chain, said Wen Shuhao, co-founder and chairman of XtalPi. He noted that expanding global businesses in China and making European and American companies pay for technology can be a successful path. http://t.cn/A6Cy32sq